ProQR Therapeutics: Looks Interesting Ahead Of Next Year’s Pivotal Data
by-studio/iStock via Getty Images
ProQR Therapeutics (PRQR) is a Dutch company developing RNA-based therapies for inherited retinal diseases or IRDs. The company was founded by CEO Daniel de Boer and is targeting cystic fibrosis
